Skip to main content

Table 1 Significance of variations of the parameters amongst the experimental groups

From: Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice

Vs

D2-OID

VD3

D2-OID + VD3

D2-specific IgG2a (serum)

 Sham

n.s.

*

**

 D2-OID

 

*

**

 VD3

  

*

IL-4 (BALF/lung homogenate)

 Sham

*

*

**

 D2-OID

 

n.s.

*

 VD3

  

*

IL-13 (BALF/lung homogenate)

 Sham

n.s

n.s.

**

 D2-OID

 

n.s.

*

 VD3

  

n.s.

IL-10 (BALF/lung homogenate)

 Sham

*

**

***

 D2-OID

 

*

**

 VD3

  

*

IFN-γ (BALF/lung homogenate)

 Sham

n.s.

n.s.

*

 D2-OID

 

n.s.

n.s.

 VD3

  

n.s.

TNF-α (BALF/lung homogenate)

 Sham

*

*

**

 D2-OID

 

n.s.

n.s.

 VD3

  

n.s.

IL-6 (BALF/lung homogenate)

 Sham

n.s.

n.s.

*

 D2-OID

 

n.s.

n.s.

 VD3

  

n.s.

Treg (FoxP3+ CD25+  % of CD4+, spleen)

 Sham

*

**

**

 D2-OID

 

*

*

 VD3

  

n.s

Treg (FoxP3:CD3, lung)

 Sham

*

*

***

 D2-OID

 

n.s.

**

 VD3

  

**

Eosinophils (lung)

 sham

n.s.

P = 0.02

(0.01)**

 D2-OID

 

(0.05)*

P = 0.02

 VD3

  

P = 0.051

  1. *p < 0.05, **p < 0.01, ***p < 0.001